What we do

Systematic Tracking of at RIsk Medicine (STARmeds) is a study cllaboration between Univeristas Pancasila, Imperial College London and Erasmus University Rotterdam. It is a 3-year study funded by the National Institute for Health Research (NIHR). It was started in November 2022 and expected to be completed by October 2023. The aim of STARmeds is to protect the public form the...

Study Period: October 2022 – March 2023 The aim of this study is to assist Bappenas in study the strengthening of drug control system in Indonesia. THis study provides background input to RPJMN 2025-2029. The objective of out this study include: To assist the Directorate of KGM Bappenas in reviewing the burden of sub-standard and falsified medicines, medicines side effect,...

Collaboration with National Social Health Insurance Agency (BPJS Kesehatan) Study Periode: July – November 2022 The aim of this study is to identify opportunities and constraints in increasing access and availability of JKN drugs. The objectives of this study are: To identify the root cause of drug shortages in the JKN drugs supply and service chain in relation to the...

Study on the Availability, Price, and Affordability of Independent Blood Glucose Measuring Device in Indonesia Collaboration with Health Action International (HAI) Study Periode : August 2022 – February 2023 This study aims to evaluate and compare the availability, price (prive procured by government and price paid by patients/private sector) and afordability of: Self-monitoring blood glucose (SMBG) tools include a glucometer,...